Mony J. De Leon
#154,414
Most Influential Person Now
Mony J. De Leon's AcademicInfluence.com Rankings
Mony J. De Leonphilosophy Degrees
Philosophy
#8681
World Rank
#12105
Historical Rank
Logic
#5710
World Rank
#7131
Historical Rank
Mony J. De Leonbiology Degrees
Biology
#11796
World Rank
#15220
Historical Rank
Neuroscience
#1942
World Rank
#1998
Historical Rank
Download Badge
Philosophy Biology
Mony J. De Leon's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Neuroscience University of California, San Francisco
Why Is Mony J. De Leon Influential?
(Suggest an Edit or Addition)Mony J. De Leon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Global Deterioration Scale for assessment of primary degenerative dementia. (1982) (4573)
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (2009) (1139)
- Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. (2015) (1112)
- Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. (2001) (863)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Hippocampal and entorhinal atrophy in mild cognitive impairment (2007) (706)
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias (2008) (669)
- Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) (2001) (627)
- The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes (2010) (500)
- Global Deterioration Scale (GDS). (1988) (493)
- Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease (2008) (474)
- Clearance systems in the brain-implications for Alzheimer disease. (2015) (434)
- The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. (1993) (346)
- Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly (2003) (324)
- Reduced hippocampal metabolism in MCI and AD (2005) (323)
- Hippocampal atrophy in normal aging. An association with recent memory impairment. (1993) (314)
- Sleep-disordered breathing advances cognitive decline in the elderly (2015) (301)
- Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. (1986) (281)
- Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease (1998) (273)
- Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease (2008) (273)
- Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. (2003) (269)
- Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. (2006) (259)
- Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. (1991) (242)
- Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. (2010) (242)
- Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism (2007) (234)
- Cortisol differentially affects memory in young and elderly men. (2001) (222)
- MRI and CSF studies in the early diagnosis of Alzheimer's disease (2004) (212)
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry (2017) (209)
- Computed Tomography and Positron Emission Transaxial Tomography Evaluations of Normal Aging and Alzheimer's Disease (1983) (207)
- Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. (1994) (203)
- Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease (2007) (201)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
- Relationships between Regional Neuronal Loss and Neurofibrillary Changes in the Hippocampal Formation and Duration and Severity of Alzheimer Disease (1997) (198)
- Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. (1992) (182)
- Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease (2009) (181)
- Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. (1997) (180)
- Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link (2018) (177)
- Positron emission tomographic studies of aging and Alzheimer disease. (1983) (175)
- Imaging markers for Alzheimer disease (2013) (174)
- Subjective Memory Complaints: Presence, Severity and Future Outcome in Normal Older Subjects (2007) (170)
- Stage‐specific behavioral, cognitive, and in vivo changes in community residing subjects with age‐associated memory impairment and primary degenerative dementia of the Alzheimer type (1988) (166)
- Age and diagnostic performance of Alzheimer disease CSF biomarkers (2012) (163)
- Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE (2015) (161)
- Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults (2018) (153)
- Hippocampal formation size predicts declining memory performance in normal aging (1996) (149)
- CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. (1990) (149)
- Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. (2008) (144)
- Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. (2011) (142)
- Effects of naloxone in senile dementia: a double-blind trial. (1983) (140)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
- Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study (2017) (135)
- GREATER RISK OF ALZHEIMER'S DISEASE IN OLDER ADULTS WITH INSOMNIA (2011) (132)
- Microglial activation and tau propagate jointly across Braak stages (2021) (129)
- Contribution of Structural Neuroimaging to the Early Diagnosis of Alzheimer's Disease (1997) (129)
- Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. (1995) (126)
- Increased fibrillar amyloid-β burden in normal individuals with a family history of late-onset Alzheimer’s (2010) (126)
- Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. (2013) (122)
- Association of Cerebral Amyloid-&bgr; Aggregation With Cognitive Functioning in Persons Without Dementia (2018) (116)
- Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly. (2016) (114)
- Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. (2014) (114)
- Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research. (2019) (112)
- Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET (2017) (112)
- MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease (2004) (111)
- Mild cognitive impairment (MCI): a historical perspective (2008) (110)
- Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease. (2013) (107)
- Sex differences in Alzheimer risk (2017) (106)
- Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. (2015) (106)
- Alzheimer's disease: longitudinal CT studies of ventricular change. (1989) (104)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- Positron Emission Tomography and Computed Tomography Assessments of the Aging Human Brain (1984) (99)
- Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies. (1986) (97)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery (2017) (90)
- MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures. (1998) (89)
- Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging (2013) (88)
- Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study (2018) (86)
- Basal Hypothalamo-Pituitary-Adrenal Axis Activity and Corticotropin Feedback in Young and Older Men: Relationships to Magnetic Resonance Imaging-Derived Hippocampus and Cingulate Gyrus Volumes (2002) (86)
- Surgery and Brain Atrophy in Cognitively Normal Elderly Subjects and Subjects Diagnosed with Mild Cognitive Impairment (2012) (82)
- APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls (2015) (81)
- Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. (2011) (81)
- Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies (2009) (79)
- Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease (2019) (79)
- Does mild cognitive impairment increase the risk of developing postoperative cognitive dysfunction? (2010) (78)
- Maternal transmission of Alzheimer's disease: Prodromal metabolic phenotype and the search for genes (2010) (77)
- Mortality and Temporal Course of Probable Alzheimer's Disease: A 5-Year Prospective Study (1996) (77)
- Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. (2008) (76)
- 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. (1982) (74)
- Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
- Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome (2011) (73)
- Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study (2014) (70)
- Hippocampal atrophy correlates with severe cognitive impairment in elderly patients with suspected normal pressure hydrocephalus. (1994) (70)
- Ventricular volume and cognitive deficit: a computed tomographic study. (1983) (69)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- Atrophy rate in medial temporal lobe during progression of Alzheimer disease (2004) (69)
- Framingham Cardiovascular Risk Profile Correlates with Impaired Hippocampal and Cortical Vasoreactivity to Hypercapnia (2011) (68)
- Wandering and parietal signs in senile dementia of Alzheimer's type. (1984) (67)
- CT prognostic criteria of survival after malignant glioma surgery. (1983) (66)
- Principal axes and surface fitting methods for three-dimensional image registration. (1993) (66)
- Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. (2009) (66)
- Abnormal Temporal Lobe Response in Alzheimer's Disease during Cognitive Processing as Measured by 11C-2-Deoxy-D-Glucose and PET (1987) (64)
- Hippocampal Atrophy Disrupts Transfer Generalization in Nondemented Elderly (2002) (63)
- 18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease (2007) (60)
- Focal dilation and paradoxical collapse of cortical fissures and sulci in patients with normal-pressure hydrocephalus. (1998) (59)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation. (1989) (59)
- Volumetric measurement of the hippocampus, the anterior cingulate cortex, and the retrosplenial granular cortex of the rat using structural MRI. (2002) (59)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- Early Detection of Alzheimer’s Disease with PET Imaging (2010) (55)
- The hippocampus in aging and Alzheimer's disease. (1995) (54)
- Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study (2014) (53)
- Regional correlation of PET and CT in senile dementia of the Alzheimer type. (1983) (52)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- Sex-driven modifiers of Alzheimer risk (2020) (52)
- Parenchymal CT correlates of senile dementia (Alzheimer disease): loss of gray-white matter discriminability. (1981) (52)
- Periodontal disease as a possible cause for Alzheimer's disease. (2020) (51)
- Sleep oscillation-specific associations with Alzheimer’s disease CSF biomarkers: novel roles for sleep spindles and tau (2019) (50)
- Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition (2021) (48)
- Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity (2018) (48)
- Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: a cross-sectional study of middle-aged adults from the broader New York City area (2018) (47)
- Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) (2020) (45)
- Abnormal Intracellular Accumulation and Extracellular Aβ Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders (2012) (44)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. (2022) (44)
- Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD (2014) (43)
- Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome (2016) (41)
- Magnetic resonance and PET studies in the early diagnosis of Alzheimer’s disease (2004) (41)
- Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects. (2016) (40)
- Positron emission tomography in dementia. (1983) (40)
- Nonspecific leukoencephalopathy associated with aging. (1995) (38)
- Challenges associated with biomarker-based classification systems for Alzheimer's disease (2018) (37)
- Longitudinal CT study of parenchymal brain changes in glioma survivors. (1988) (36)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease. (2005) (36)
- Peri-Operative Inflammatory Cytokines in Plasma of the Elderly Correlate in Prospective Study with Postoperative Changes in Cognitive Test Scores. (2016) (35)
- Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease. (2015) (34)
- Altered glucose metabolism in microvessels from patients with Alzheimer's disease (1989) (33)
- The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer’s disease (2018) (32)
- FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease (2014) (32)
- Hippocampal cerebrospinal fluid spaces on MR imaging: Relationship to aging and Alzheimer disease. (2006) (31)
- Computed tomography in aging and senile dementia of the Alzheimer type. (1983) (31)
- Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
- Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects (2016) (27)
- Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension (2019) (27)
- Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
- Associations of lifestyle and vascular risk factors with Alzheimer’s brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area (2018) (26)
- Significance of age-related white matter lesions. (1988) (26)
- The differential diagnosis of Alzheimer's disease. Cerebral atrophy versus normal pressure hydrocephalus. (1995) (25)
- Novel pharmacologic approaches to the treatment of senile dementia of the Alzheimer's type (SDAT). (1983) (23)
- Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease. (2016) (23)
- Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease (2021) (22)
- Anteroposterior hippocampal metabolic heterogeneity: three-dimensional multivoxel proton 1H MR spectroscopic imaging--initial findings. (2008) (22)
- Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly. (2013) (21)
- Hippocampal blood flow in normal aging measured with arterial spin labeling at 3T (2011) (21)
- Prefrontal N-acetylaspartate and poststroke recovery: a longitudinal proton spectroscopy study. (2007) (21)
- Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease (2015) (20)
- Midbrain Atrophy in Vascular Parkinsonism (2011) (20)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study (2017) (19)
- Imaging the brain in dementia: expensive and futile? (1997) (18)
- Comparison of the Brain Volume in Essential Tremor and Parkinson's Disease Tremor Using an Automated Segmentation Method (2015) (16)
- The perihippocampal fissures: normal anatomy and disease states. (1998) (16)
- Resting-State Glucose Metabolism Level Is Associated with the Regional Pattern of Amyloid Pathology in Alzheimer's Disease (2011) (15)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Dilatation of the lateral part of the transverse fissure of the brain in Alzheimer's disease. (1993) (14)
- Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms (2013) (14)
- Letter to the editor regarding: Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective (2015) (14)
- The relationship between psychiatric assessments and cognitive test measures in mild to moderately cognitively impaired elderly [proceedings]. (1981) (13)
- Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease. (2001) (13)
- An entorhinal cortex sulcal pattern is associated with Alzheimer's disease (2009) (13)
- Multiregional Age-Associated Reduction of Brain Neuronal Reserve Without Association With Neurofibrillary Degeneration or &bgr;-Amyloidosis (2017) (12)
- Elevated Cerebellar Glucose Metabolism in Microvascular White Matter Disease: Normal Aging and Alzheimer's Disease (1988) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- Positron emission tomography of hydrocephalus. Metabolic effects of shunt procedures. (1986) (12)
- Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly (2021) (11)
- Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery (2018) (11)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- Quantitative Water Permeability Mapping of Blood-Brain-Barrier Dysfunction in Aging (2022) (10)
- Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
- Publisher Correction: Microglial activation and tau propagate jointly across Braak stages (2021) (8)
- Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non‐demented state (2017) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Therapeutic potential for peripheral clearance of misfolded brain proteins (2018) (7)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology. (2009) (7)
- Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD (2001) (7)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- Heuristic scoring method utilizing FDG-PET statistical parametric mapping in the evaluation of suspected Alzheimer disease and frontotemporal lobar degeneration. (2021) (6)
- Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment). (2019) (6)
- Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
- Developmental deficits and staging of dynamics of age associated Alzheimer’s disease neurodegeneration and neuronal loss in subjects with Down syndrome (2022) (6)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease. (2020) (6)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- Cognitive dysfunction in young subjects with periodontal disease (2021) (5)
- Relationship between cognition and mood in geriatric depression. (1982) (4)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- Spatial relationships between white matter degeneration, amyloid load and cortical volume in amnestic mild cognitive impairment (2018) (4)
- Periventricular high signal lesions and signal void on magnetic resonance imaging in hydrocephalus. Diagnostic and prognostic significance. (1986) (4)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's. (2021) (4)
- Fibrillar amyloid-β affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration (2001) (4)
- Obesity and Race May Explain Differential Burden of White Matter Hyperintensity Load (2021) (4)
- Obstructive Sleep Apnea and Hypertension with Longitudinal β-Amyloid Burden and Cognitive Changes. (2022) (3)
- The Brain-Nose Interface: A Potential Cerebrospinal Fluid Clearance Site in Humans (2022) (3)
- Statistical Parametric Mapping in Amyloid Positron Emission Tomography (2022) (3)
- Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment (2022) (3)
- Association between liver fibrosis and incident dementia in the UK Biobank study (2022) (3)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
- Evaluation of Early Dementia (Mild Cognitive Impairment). (2010) (3)
- Precisely-Measured Hydration Status Correlates with Hippocampal Volume in Healthy Older Adults. (2019) (2)
- Bayesian Applications to Longitudinal Analysis on Medical Data with Discrete Outcomes (2005) (2)
- Synthesis of [1-11C]Butanol via a facile solid phase extraction protocol. (2020) (2)
- Altered patterns of positron-emission tomography glucose metabolism in Alzheimer patients with microvascular white matter disease. (1988) (2)
- Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer’s Disease Subjects (2021) (2)
- Inge Grundke-Iqbal, Ph.D. (1937–2012): the Discoverer of the Abnormal Hyperphosphorylation of Tau in Alzheimer’s Disease (2013) (2)
- Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals (2022) (1)
- Ordering of Alzheimer disease biomarkers. (2012) (1)
- Association of Liver Fibrosis with Cognitive Test Performance and Brain Volume Changes in the UK Biobank Study (2022) (1)
- PET‐DEOXYGLUCOSE, CT AND NEUROPATHOLOGY STUDIES OF AGE RELATED WHITE MATTER PATHOLOGY IN NORMALS AND ALZHEIMER DISEASE (1988) (1)
- Positron Emission Tomography reveals age-associated hypothalamic microglial activation in women (2022) (1)
- Interactive Associations of Neuropsychiatry Inventory-Questionnaire Assessed Sleep Disturbance and Vascular Risk on Alzheimer’s Disease Stage Progression in Clinically Normal Older Adults (2021) (1)
- Foreword (2007) (0)
- A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
- Targeting Succinate Receptor Reduces Microglial Activation and Neuroinflammation (2022) (0)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
- Reduced glymphatic function after traumatic brain injury measured using diffusion MRI (2022) (0)
- Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
- Spatial distribution of residual error in 3D image coregistration: an experimental study (1997) (0)
- Effects of blood pressure on white matter lesions and brain volumes in hypertensive and normotensive subjects (2021) (0)
- Traumatic brain injury and age at onset of cognitive decline in corticobasal degeneration, corticobasal syndrome, and progressive supranuclear palsy (2021) (0)
- CLINICAL CHARACTERISTICS OF DEMENTIA OF THE ALZHEIMER TYPE (AD) (1988) (0)
- Neurodegeneration blood markers in largely Hispanic and non‐Hispanic Black COVID‐19 patients: from acute hospitalization to long‐term PASC with/without brain fog (2022) (0)
- Higher body mass index is associated with worse hippocampal vasoreactivity to carbon dioxide (2022) (0)
- CSF biomarkers and blood pressure trajectories in normotensive individuals and subjects with controlled and uncontrolled hypertension (2021) (0)
- Regional deconvolution method for partial volume correction in brain PET (2001) (0)
- Traumatic brain injury accelerates Parkinson’s disease onset without altering Parkinson’s neuropathology (2021) (0)
- Quadratic relationship between systolic blood pressure and white matter lesions in individuals with hypertension (2022) (0)
- The Alzheimer's Imaging Consortium: Celebrating 20 years of creativity and progress (2016) (0)
- Erratum to: Inge Grundke-Iqbal, Ph.D. (1937–2012): the Discoverer of the Abnormal Hyperphosphorylation of Tau in Alzheimer’s Disease (2013) (0)
- Reply: Cerebrospinal Fluid, Hyposmia, and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis (2018) (0)
- The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
- Association between lower body temperature and increased tau pathology in cognitively normal older adults (2021) (0)
- Sleep oscillation-specific associations with Alzheimer’s disease CSF biomarkers: novel roles for sleep spindles and tau (2019) (0)
- GenEpi: gene-based epistasis discovery using machine learning (2020) (0)
- The LUCINDA trial: Leuprolide + cholinesterase inhibition to reduce neurologic decline in Alzheimer's (2020) (0)
- Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- Diffusion MRI Changes in the Healthy Aging Canine Brain (2020) (0)
- Multimodal Imaging Analysis for Brain Clearance: PET Imaging Based Clearance Slope, FASTT2 MRI‐based Parenchyma CSF fraction, and DTI‐based ALPS‐index (2022) (0)
This paper list is powered by the following services:
